Concept Companies and Lacerta Therapeutics Form a Strategic Partnership Around Facilities Expansion and Financing
Concept Companies, a national commercial real estate developer with a specialty across multiple asset classes including science and technology, and Lacerta Therapeutics, Inc., a leader in the AAV gene therapy space, today announced a strategic collaboration providing Lacerta with access to financing to support expansion of operations and new facilities. The financing is being provided via Agility Venture Capital, the funding arm of Concept Companies.
UF Researchers Use AI To Predict New Coronavirus Variants
A new research grant led by University of Florida professors and is attempting to see if AI can help predict the next wave of coronavirus.
Lacerta and Prevail, a Wholly Owned Subsidiary of Lilly, Sign Agreement To Develop Novel AAV Capsids for CNS Disorders
Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid licensing and research collaboration agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company. The collaboration will focus on the discovery and development of novel AAV capsids for CNS diseases.
UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol
UF Scripps Biomedical Research scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.
Cade Prize Announces Fibonacci Finalists
Judges for 2022’s Cade Prize for Innovation named this year’s 21 Fibonacci Finalists. The finalists, from Florida, Georgia and Alabama, will compete for $64,000 of prize money. Winners will be announced September 29, 2022.
UF Accelerate Residents Announced As Finalists for the 12th Annual GrowFL Florida Companies To Watch
UF Accelerate | Sid Martin Biotech resident Neobiosis, and UF Accelerate | The Hub resident Quottly, have been selected as finalists for this year's annual GrowFL Florida companies to watch.
UF Health research sheds new light on nicotine and morning brew
In a cell-based study, UF researchers identified two compounds in coffee that directly affect certain high-sensitivity nicotine receptors in the brain. In smokers, these brain receptors can be hypersensitive after a night of nicotine withdrawal.
UF Researchers Refining Wastewater Health Signals
University of Florida investigators in the College of Public Health and Health Professions (PHHP), the College of Veterinary Medicine, and the Emerging Pathogens Institute—have spent the past two years building testing capacity and refining wastewater analysis techniques to better detect viruses, bacteria and even chemical markers of health—such as pesticides and illegal drugs.
My Tutor Is an AI: UF Researchers Seek Out if AI Tutors Are As Effective as Human Ones
Artificial Intelligence is now being used to help tutor students at all educational levels. AI tutors can enhance learning outcomes such as facilitating various teaching-learning practices within and outside the classroom, supporting students 24/7, and providing students from economically disadvantaged areas access to all kinds of learning materials without being in the same geographical location.
UF Scientists Probe the Cosmos With the New James Webb Space Telescope
The James Webb Space Telescope launched on Christmas Day, 2021, and the instrument was so complex that it took months for us to peer through the new telescope. Then in July of 2022 we got our first look at images from the most advanced space observatory ever made. The telescope’s data will transform how we understand our universe, and University of Florida astronomers and physicists are on the vanguard of these discoveries.
